发明名称 |
TREATMENT METHOD FOR EPITHELIAL CANCEROUS ORGANISM |
摘要 |
It is an object of the present invention to provide a novel method for decreasing the number of clinical cases for which trastuzumab administration is ineffective. The present invention provides a method for treating a living individual with epithelial cancer comprising: step (a) of selectively reducing KLRG1-positive immunocytes in the peripheral blood of a living individual with epithelial cancer ex vivo, which is positive for a cancer-specific membrane antigen expressed in epithelial cancer cells and positive for a KLRG1 ligand; and step (b) of administering, to the living individual, a therapeutic agent for cancer comprising an antibody reacting with the cancer-specific membrane antigen expressed in epithelial cancer cells and having antibody-dependent cell cytotoxicity.
|
申请公布号 |
US2011091471(A1) |
申请公布日期 |
2011.04.21 |
申请号 |
US20100835010 |
申请日期 |
2010.07.13 |
申请人 |
ASAHI KASEI KURARAY MEDICAL CO., LTD.;NATIONAL CANCER CENTER |
发明人 |
YASUTAKE MIKITOMO;NINOMIYA KASUMI;HONDA JUNICHI;OCHIAI ATSUSHI;YAMAUCHI CHISAKO |
分类号 |
A61K39/395;A61P35/00 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|